Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.4157
-0.0350 (-7.77%)
At close: Mar 28, 2025, 4:00 PM
0.4300
+0.0143 (3.44%)
After-hours: Mar 28, 2025, 7:20 PM EDT
Cognition Therapeutics Stock Forecast
CGTX's stock price has decreased by -77.16% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Cognition Therapeutics stock have an average target of 7.50, with a low estimate of 1.50 and a high estimate of 14. The average target predicts an increase of 1,704.19% from the current stock price of 0.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cognition Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +1,102.79% | Mar 24, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +1,824.46% | Mar 21, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +2,546.14% | Feb 26, 2025 |
| B. Riley Securities | B. Riley Securities | Hold → Strong Buy Upgrades $1 → $1.5 | Hold → Strong Buy | Upgrades | $1 → $1.5 | +260.84% | Dec 19, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +2,546.14% | Dec 19, 2024 |
Financial Forecast
Revenue This Year
n/a
from 179.62M
Revenue Next Year
n/a
EPS This Year
-0.54
from -0.86
EPS Next Year
-0.65
from -0.54
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | 44.0M | ||
| Avg | n/a | n/a | 14.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.33 | -0.60 | -2.45 |
| Avg | -0.54 | -0.65 | -2.38 |
| Low | -0.85 | -0.70 | -2.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.